SNC
SPHS

Stifel Nicolaus & Co’s Sophiris Bio, Inc. SPHS Stock Holding History

Stifel Nicolaus & Co’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$84.4K Buy
+18,025
New +$83.1K ﹤0.01% 1448

Other funds holding SPHS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Stifel Nicolaus & Co's SPHS Position: Q3 2013 in Review

Stifel Nicolaus & Co opened a new position in Sophiris Bio, Inc. (SPHS) in Q3 2013: 18,025 shares worth $84.4K. The stake represents ﹤0.01% of the portfolio and ranks #1448 among its holdings.

24 funds tracked by Wall St. Rank hold SPHS as of Q3 2013.

  • Stifel Nicolaus & Co held 18,025 shares of Sophiris Bio, Inc. worth $84.4K as of Q3 2013.
  • Sophiris Bio, Inc. was a new Stifel Nicolaus & Co position in Q3 2013.
  • Sophiris Bio, Inc. made up ﹤0.01% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #1448 holding.
  • 24 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.